(Q38596356)

4 September 2017

title

Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus (English)

1 reference

4 September 2017

0 references

1

Nancy Raab-Traub

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

390

1 reference

4 September 2017

issue

Pt 1

1 reference

4 September 2017

page(s)

339-363

1 reference

Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

EBV persistence in memory B cells in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The enigmatic epidemiology of nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Modelling glandular epithelial cancers in three-dimensional cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Potential selection of LMP1 variants in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Localization of the Epstein-Barr virus protein LMP 1 to exosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

EBV gene expression in an NPC-related tumour.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Salted fish and nasopharyngeal carcinoma in southern Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

An Epstein-Barr virus protein interacts with Notch

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Replication of EBV in epithelial cells during infectious mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Detection of Antigens Associated With Epstein-Barr Virus Replication in Extracts From Biopsy Specimens of Nasopharyngeal Carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Detection and prevalence of the “f” variant of epstein-barr virus in Southern China

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Unique signaling properties of CTAR1 in LMP1-mediated transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The role of miRNAs and EBV BARTs in NPC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Human tumor virus utilizes exosomes for intercellular communication.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Modulation of B-cell exosome proteins by gamma herpesvirus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Sequence variation in the Epstein-Barr virus latent membrane protein 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Identification of virus-encoded microRNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

EBV specific CTL: a model for immune therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Efficient replication of Epstein-Barr virus in stratified epithelium in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Detection of Epstein-Barr Virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Proof for EBV's sustaining role in Burkitt's lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Clonal antigen receptor gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_14

10.1007/978-3-319-22822-8_14

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference